Investigation of cancer drug resistance mechanisms by phosphoproteomics.

Ruedi Aebersold, Matthias Mann, None, Mass-spectrometric exploration of proteome structure and function Nature. ,vol. 537, pp. 347- 355 ,(2016) , 10.1038/NATURE19949

Heiner Koch, Mathias Wilhelm, Benjamin Ruprecht, Scarlet Beck, Martin Frejno, Susan Klaeger, Bernhard Kuster, Phosphoproteome Profiling Reveals Molecular Mechanisms of Growth-Factor-Mediated Kinase Inhibitor Resistance in EGFR-Overexpressing Cancer Cells. Journal of Proteome Research. ,vol. 15, pp. 4490- 4504 ,(2016) , 10.1021/ACS.JPROTEOME.6B00621

Yufeng Wang, Yasuhiro Kuramitsu, Byron Baron, Takao Kitagawa, Kazuhiro Tokuda, Junko Akada, Shin-Ichiro Maehara, Yoshihiko Maehara, Kazuyuki Nakamura, PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells International Journal of Oncology. ,vol. 50, pp. 606- 612 ,(2017) , 10.3892/IJO.2016.3804

Anna Chorzalska, Javier Flores Kim, Karim Roder, Alexander Tepper, Nagib Ahsan, R. Shyama Prasad Rao, Adam J. Olszewski, Xiaoqing Yu, Dmitry Terentyev, John Morgan, Diana O. Treaba, Ting C. Zhao, Olin Liang, Philip A. Gruppuso, Patrycja M. Dubielecka, Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia. Stem Cells and Development. ,vol. 26, pp. 656- 677 ,(2017) , 10.1089/SCD.2016.0262

Benjamin Ruprecht, Esther A. Zaal, Jana Zecha, Wei Wu, Celia R. Berkers, Bernhard Kuster, Simone Lemeer, Lapatinib Resistance in Breast Cancer Cells Is Accompanied by Phosphorylation-Mediated Reprogramming of Glycolysis Cancer Research. ,vol. 77, pp. 1842- 1853 ,(2017) , 10.1158/0008-5472.CAN-16-2976

XU Zhang, Tapan Maity, Manoj K Kashyap, Mukesh Bansal, Abhilash Venugopalan, Sahib Singh, Shivangi Awasthi, Arivusudar Marimuthu, Harrys Kishore Charles Jacob, Natalya Belkina, Stephanie Pitts, Constance M Cultraro, Shaojian Gao, Guldal Kirkali, Romi Biswas, Raghothama Chaerkady, Andrea Califano, Akhilesh Pandey, Udayan Guha, None, Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response. Molecular & Cellular Proteomics. ,vol. 16, pp. 891- 910 ,(2017) , 10.1074/MCP.M117.067439

Wenhu Liu, Jinxia Chang, Mingwei Liu, Jiangbei Yuan, Jinqiang Zhang, Jun Qin, Xuefeng Xia, Yi Wang, Quantitative proteomics profiling reveals activation of mTOR pathway in trastuzumab resistance Oncotarget. ,vol. 8, pp. 45793- 45806 ,(2017) , 10.18632/ONCOTARGET.17415

Elizabeth V. Nguyen, Kaisa Huhtinen, Young Ah Goo, Katja Kaipio, Noora Andersson, Ville Rantanen, Johanna Hynninen, Riitta Lahesmaa, Olli Carpen, David R. Goodlett, Hyper-phosphorylation of Sequestosome-1 Distinguishes Resistance to Cisplatin in Patient Derived High Grade Serous Ovarian Cancer Cells Molecular & Cellular Proteomics. ,vol. 16, pp. 1377- 1392 ,(2017) , 10.1074/MCP.M116.058321

Stefanie Avril, Yasemin Dincer, Katharina Malinowsky, Claudia Wolff, Sibylle Gündisch, Alexander Hapfelmeier, Melanie Boxberg, Holger Bronger, Karl-Friedrich Becker, Barbara Schmalfeldt, Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients. Oncotarget. ,vol. 8, pp. 97851- 97861 ,(2017) , 10.18632/ONCOTARGET.18415

Yi-Ting Wang, Szu-Hua Pan, Chia-Feng Tsai, Ting-Chun Kuo, Yuan-Ling Hsu, Hsin-Yung Yen, Wai-Kok Choong, Hsin-Yi Wu, Yen-Chen Liao, Tse-Ming Hong, Ting-Yi Sung, Pan-Chyr Yang, Yu-Ju Chen, Phosphoproteomics Reveals HMGA1, a CK2 Substrate, as a Drug-Resistant Target in Non-Small Cell Lung Cancer. Scientific Reports. ,vol. 7, pp. 44021- 44021 ,(2017) , 10.1038/SREP44021